Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • US
      Sections
      • US Home
      • US Economy
      • US Companies
      • US Politics & Policy
      Most Read
      • Companies
        Sections
        • Companies Home
        • Energy
        • Financials
        • Health
        • Industrials
        • Media
        • Professional Services
        • Retail & Consumer
        • Tech Sector
        • Telecoms
        • Transport
        Most Read
        • Tech
        • Markets
          Sections
          • Markets Home
          • Alphaville
          • Markets Data
          • Cryptofinance
          • Capital Markets
          • Commodities
          • Currencies
          • Equities
          • Fund Management
          • Trading
          • Moral Money
          • ETF Hub
          Most Read
          • Climate
          • Opinion
            Sections
            • Opinion Home
            • Columnists
            • The FT View
            • Lex
            • Obituaries
            • Letters
            Most Read
            • Work & Careers
              Sections
              • Work & Careers Home
              • Business School Rankings
              • Business Education
              • Entrepreneurship
              • Recruitment
              • Business Books
              • Business Travel
              Most Read
              • Life & Arts
                Sections
                • Life & Arts Home
                • Arts
                • Books
                • Food & Drink
                • FT Magazine
                • House & Home
                • Style
                • Travel
                • FT Globetrotter
                Most Read
                • HTSI
                MenuSearch
                • Home
                • World
                • US
                • Companies
                • Tech
                • Markets
                • Climate
                • Opinion
                • Work & Careers
                • Life & Arts
                • HTSI
                Financial Times
                SubscribeSign In

                Jamie Smyth

                US Energy Editor

                Jamie Smyth is the US energy editor of the Financial Times. He is based in the New York bureau and manages a team covering the US oil, gas and renewables sectors. He previously worked as the FT’s US pharmaceutical correspondent, Australia correspondent and Ireland correspondent.

                Prior to the FT he reported for The Irish Times newspaper in Brussels and Dublin.

                Email Jamie Smyth @JamieSmythF  on Twitter (link opens in a new browser window)

                Add to myFT Digest

                Add this topic to your myFT Digest for news straight to your inbox

                • Tuesday, 3 October, 2023
                  US Inflation Reduction Act
                  Siemens’ US chief urges strong message to voters on Biden subsidies

                  Executives fear Republicans will repeal clean energy tax breaks if they win in 2024

                  Barbara Humpton
                • Monday, 2 October, 2023
                  News in-depthShale Oil & Gas
                  US shale bosses vow to hold back drilling despite rising oil price

                  Producers say Biden’s ‘war’ on fossil fuels and Wall Street’s insistence on capital discipline limit expansion

                  A view looking up to an oil worker hanging from a climbing harness at a shale oil field in North Dakota
                • Sunday, 1 October, 2023
                  US presidential election 2024
                  Some Republican donors worry legal troubles will win nomination for Trump

                  Former US president’s lead over Republican rivals grows as prosecutors lay out cases against him

                  A Trump spoorter walking past Trump’s campaign poster
                • Friday, 29 September, 2023
                  BP PLC
                  BP tells staff top US executive is leaving just weeks after CEO exit

                  Departure follows resignation of Bernard Looney

                  BP sign on a building
                • Friday, 29 September, 2023
                  Oil & Gas industry
                  Biden administration plans record-low number of offshore drilling leases

                  Five-year plan offers drastic reduction compared with Trump-era proposal despite industry lobbying

                  A drilling derrick on a BP platform in the Gulf of Mexico
                • Sunday, 24 September, 2023
                  InterviewEU energy
                  Top EU energy official says US gas will be needed for decades

                  Bloc will have a ‘need for American energy’ says Ditte Juul Jørgensen

                  Workers at the Cheniere Sabine Pass liquefaction facility in Cameron, Louisiana
                • Wednesday, 20 September, 2023
                  FT News Briefing podcast13 min listen
                  Oil prices are not a barrel of fun

                  Instacart shares close up 12% after public market debut

                • Wednesday, 20 September, 2023
                  US presidential election 2024
                  DeSantis leads charge to pry Texas oil donors from Trump

                  Onetime supporters of ex-president are hunting for an alternative to roll back Biden’s green agenda

                  Florida governor Ron DeSantis addresses a crowd in Texas
                • Monday, 18 September, 2023
                  The Big Read
                  The Biden administration takes on the US drugs industry

                  New rules are designed to make medicines cheaper for American seniors. But companies warn innovation will suffer

                • Sunday, 17 September, 2023
                  Oil & Gas industry
                  California accuses Big Oil of covering up climate change risks in lawsuit

                  Civil action seeks damages to help mitigate costs of global warming caused by fossil fuels

                  Firefighters spray water in the Sequoia National Forest, California
                • Friday, 15 September, 2023
                  ExplainerOil
                  Why oil is back to $90 a barrel

                  Saudi Arabia and Russia have curtailed supplies in the face of record global demand

                  Pump jack in Loco Hills region, New Mexico
                • Thursday, 14 September, 2023
                  Energy Source
                  Joe Biden is stuck on the gasoline price elevator Premium content

                  Also in today’s newsletter, the projected cost of hitting net zero

                  Petrol prices over $5 a gallon at a gas station
                • Tuesday, 5 September, 2023
                  Illumina Inc
                  Illumina appoints new CEO after battle with investors

                  Biotech has been criticised for closing its $8bn acquisition of cancer test company Grail without regulatory approval

                  Illumina’s global headquarters in San Diego, California
                • Sunday, 3 September, 2023
                  Vivek Ramaswamy
                  Vivek Ramaswamy’s FDA ‘corruption’ claims disavowed by Roivant

                  Biotech company rejects founder and Republican presidential hopeful’s criticism of US drug regulator

                  Former biotech executive Vivek Ramaswamy in the spin room following the Republican primary debate in Milwaukee, Wisconsin
                • Tuesday, 29 August, 2023
                  US politics & policy
                  US targets 10 drugs for pricing negotiations in crackdown on costs

                  Expensive medicines made by Pfizer, J&J and Merck selected for talks in biggest shake-up in decades

                  A pharmacist holds a bottle of the drug Eliquis, sold by Bristol Myers Sqibb and Pfizer
                • Tuesday, 29 August, 2023
                  3M Co
                  3M agrees historic $6bn settlement over combat earplug lawsuits

                  Post-it note maker to resolve mass US tort litigation brought by more than 250,000 military veterans

                  3M signage outside the company’s plant in Ames, Iowa
                • Monday, 28 August, 2023
                  FT News Briefing podcast10 min listen
                  In search of a new economic playbook

                  Chinese corporate earnings reports this week are forecast to log poor performance

                • Sunday, 27 August, 2023
                  News in-depthEU economy
                  Ireland seeks to lure life science investment despite corporate tax rise

                  Dublin believes that the country’s skill base will attract pharma and medical companies

                • Saturday, 26 August, 2023
                  News in-depthUS presidential election 2024
                  From biotech booster to Republican contender: the rise of Vivek Ramaswamy

                  Presidential candidate makes polling gains by capitalising on image as successful businessman

                  Vivek Ramaswamy on stage during the TV debate
                • Friday, 25 August, 2023
                  AstraZeneca PLC
                  AstraZeneca sues US government over drug price reforms

                  Anglo-Swedish group is latest to challenge Medicare’s new power to negotiate prices for a limited number of medicines

                  Assembly line at AstraZeneca manufacturing plant
                • Tuesday, 22 August, 2023
                  Pharmaceuticals sector
                  Use of horseshoe crabs’ blue blood puts pharma groups under scrutiny

                  BNP Paribas joins environmentalists in pressing companies to run toxin tests with synthetic substances

                  Person holds a horseshoe crab
                • Sunday, 13 August, 2023
                  Drugs research
                  Eli Lilly achieves hard-won success with Alzheimer’s and obesity drugs

                  US pharmaceutical group says it wants to become the first trillion dollar healthcare company

                  A pharmacist displays a box of Eli Lilly’s Mounjaro diabetes and weight loss treatment
                • Thursday, 10 August, 2023
                  Purdue Pharma LP
                  Supreme Court halts $6bn Purdue opioid settlement in blow to Sacklers

                  Justices will consider whether the law permits the waiver of future claims against parties not in bankruptcy

                  A pharmacist holds a bottle of OxyContin
                • Wednesday, 9 August, 2023
                  FT News Briefing podcast9 min listen
                  The weight-loss drug craze

                  US bank stocks stumble after Moody’s cut ratings of midsized lenders

                • Tuesday, 8 August, 2023
                  Novo Nordisk AS
                  Novo Nordisk’s obesity drug cuts risk of strokes and heart attacks

                  Shares in Danish drugmaker and US rival Eli Lilly surge to record highs after positive trial of weight-loss drug

                  Injector pens for the Wegovy weight loss drug in a box
                Previous page You are on page 1 Next page

                Useful links

                Support

                View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

                Legal & Privacy

                Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

                Services

                Share News Tips SecurelyIndividual SubscriptionsProfessional SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on XFT ChannelsFT Schools

                Tools

                PortfolioToday’s Newspaper (FT Digital Edition)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

                Community & Events

                FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

                More from the FT Group

                Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
                The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
                Financial Times

                International Edition

                Subscribe for full access
                • Switch to UK Edition

                Top sections

                • Home
                • World
                  • Global Economy
                  • UK
                  • US
                  • China
                  • Africa
                  • Asia Pacific
                  • Emerging Markets
                  • Europe
                  • War in Ukraine
                  • Americas
                  • Middle East & North Africa
                  • Australia & NZ
                • US
                  • US Economy
                  • US Companies
                  • US Politics & Policy
                • Companies
                  • Energy
                  • Financials
                  • Health
                  • Industrials
                  • Media
                  • Professional Services
                  • Retail & Consumer
                  • Tech Sector
                  • Telecoms
                  • Transport
                • Tech
                • Markets
                  • Alphaville
                  • Markets Data
                  • Cryptofinance
                  • Capital Markets
                  • Commodities
                  • Currencies
                  • Equities
                  • Fund Management
                  • Trading
                  • Moral Money
                  • ETF Hub
                • Climate
                • Opinion
                  • Columnists
                  • The FT View
                  • Lex
                  • Obituaries
                  • Letters
                • Work & Careers
                  • Business School Rankings
                  • Business Education
                  • Entrepreneurship
                  • Recruitment
                  • Business Books
                  • Business Travel
                • Life & Arts
                  • Arts
                  • Books
                  • Food & Drink
                  • FT Magazine
                  • House & Home
                  • Style
                  • Travel
                  • FT Globetrotter
                • Personal Finance
                  • Property & Mortgages
                  • Investments
                  • Pensions
                  • Tax
                  • Banking & Savings
                  • Advice & Comment
                  • Next Act
                • HTSI
                • Special Reports

                FT recommends

                • Lex
                • Alphaville
                • Lunch with the FT
                • FT Globetrotter
                • #techAsia
                • Moral Money
                • Visual and data journalism
                • Newsletters
                • Video
                • Podcasts
                • News feed
                • FT Live Events
                • FT Forums
                • Board Director Programme
                • myFT
                • Portfolio
                • Today’s Newspaper (FT Digital Edition)
                • Crossword
                • Our Apps
                • Help Centre
                • Subscribe
                • Sign In